100
Participants
Start Date
February 15, 2021
Primary Completion Date
April 30, 2026
Study Completion Date
July 30, 2026
L-Dopa
"Generic 25/100mg carbidopa/levodopa (Sinemet)capsules will be administered in this study. Participants will begin randomized double blinded 3- week trial of Levodopa. Dose titration starting at 150 mg /daily to maximum of 450 mg daily three times a day for three weeks.~After one week of taper participants will enter step 2 phase of study where carbidopa/levodopa matched placebo will be administered for 3 weeks afterwards dose will be slowly tapered over next 7 days."
Placebo
Step 1 (3 weeks) Carbidopa/levodopa-matched placebo capsules 3 times. Followed by 1 week of taper. Step2(3 weeks):150-450mg carbidopa/levodopa 3 times daily for three weeks .Followed by 1 week of taper.
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
Vanderbilt Psychiatric Hospital, Nashville
Emory University
OTHER
University of Pittsburgh
OTHER
University of Pittsburgh Medical Center
OTHER
Rutgers University
OTHER
Vanderbilt University Medical Center
OTHER